A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. The research team discovered that a gene called MAGP2 — not previously associated with any type of cancer — was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.
Possible ovarian cancer treatment target identified
December 10th, 2009 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.